256 related articles for article (PubMed ID: 21822526)
1. Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis?
Pabinger I; Ay C
Hamostaseologie; 2012; 32(2):132-7. PubMed ID: 21822526
[TBL] [Abstract][Full Text] [Related]
2. Risk assessment models for cancer-associated venous thromboembolism.
Dutia M; White RH; Wun T
Cancer; 2012 Jul; 118(14):3468-76. PubMed ID: 22086826
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, risk and outcomes of venous thromboembolism in cancer.
Falanga A; Russo L
Hamostaseologie; 2012; 32(2):115-25. PubMed ID: 21971578
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
Thaler J; Ay C; Pabinger I
Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
[TBL] [Abstract][Full Text] [Related]
5. Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
Aikens GB; Rivey MP; Hansen CJ
Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
Bergmann JF; Cohen AT; Tapson VF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Anderson FA;
Thromb Haemost; 2010 Apr; 103(4):736-48. PubMed ID: 20135072
[TBL] [Abstract][Full Text] [Related]
7. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
8. Does ambulation modify venous thromboembolism risk in acutely ill medical patients?
Amin AN; Girard F; Samama MM
Thromb Haemost; 2010 Nov; 104(5):955-61. PubMed ID: 20838741
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis and treatment of venous thromboembolism in cancer patients: a review.
Ansell JE
Am J Clin Oncol; 2009 Aug; 32(4 Suppl):S8-S12. PubMed ID: 19654482
[TBL] [Abstract][Full Text] [Related]
10. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
Merli GJ
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism following primary total hip arthroplasty.
Hitos K; Fletcher JP
Int Angiol; 2009 Jun; 28(3):215-21. PubMed ID: 19506541
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification and utilisation of thrombo-embolism prophylaxis in a medical-surgical ICU: a hospital-based study.
Ansari K; Dalal K; Patel M
J Indian Med Assoc; 2007 Sep; 105(9):536, 538, 540 passim. PubMed ID: 18338482
[TBL] [Abstract][Full Text] [Related]
13. VTE risk assessment in cancer. Who needs prophylaxis and who does not?
Ay C; Pabinger I
Hamostaseologie; 2015; 35(4):319-24. PubMed ID: 25740182
[TBL] [Abstract][Full Text] [Related]
14. New strategies of VTE prevention in cancer patients.
Verso M; Agnelli G
Thromb Res; 2014 May; 133 Suppl 2():S128-32. PubMed ID: 24862133
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism prophylaxis in medical ICU patients in Asia (VOICE Asia): a multicenter, observational, cross-sectional study.
Parikh KC; Oh D; Sittipunt C; Kalim H; Ullah S; Aggarwal SK;
Thromb Res; 2012 Apr; 129(4):e152-8. PubMed ID: 22326367
[TBL] [Abstract][Full Text] [Related]
16. Management of venous Thromboembolism in cancer: a brief review of risk-benefit approaches and guidelines' recommendations.
Djulbegovic B
J Support Oncol; 2010; 8(2):84-91. PubMed ID: 20464888
[TBL] [Abstract][Full Text] [Related]
17. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
18. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
20. Treatment and secondary prevention of venous thromboembolism in cancer patients. Current strategies and new therapeutic options.
Ay C; Pabinger I
Hamostaseologie; 2012; 32(2):139-44. PubMed ID: 21822525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
